IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,031,038 | +1.6% | 159,678 | +19.1% | 0.03% | +21.4% |
| Q3 2022 | $5,938,000 | -35.1% | 134,081 | -55.4% | 0.03% | -9.7% |
| Q4 2021 | $9,153,000 | +2592.1% | 300,797 | +3426.3% | 0.03% | +3000.0% |
| Q2 2021 | $340,000 | +33.9% | 8,530 | +50.7% | 0.00% | 0.0% |
| Q1 2021 | $254,000 | +16.0% | 5,659 | +46.3% | 0.00% | 0.0% |
| Q4 2020 | $219,000 | -95.0% | 3,867 | -95.8% | 0.00% | -96.9% |
| Q3 2020 | $4,363,000 | +801.4% | 91,956 | +1020.0% | 0.03% | +700.0% |
| Q2 2020 | $484,000 | -92.5% | 8,210 | -91.8% | 0.00% | -91.8% |
| Q2 2019 | $6,420,000 | +235.2% | 99,891 | +316.0% | 0.05% | +308.3% |
| Q1 2019 | $1,915,000 | +258.6% | 24,011 | +98.2% | 0.01% | +300.0% |
| Q1 2018 | $534,000 | – | 12,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |